Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

BN FINANCIAL STATEMENTS

Danone SA — balance sheet, income statement and cash flow trends

BNDanone SA

🇫🇷 France · PA · Consumer Defensive · Packaged Foods

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
010 B20 B202020212022202320242025

Profit Funnel

Q2 2025 · TTM
Revenue27.3 B €Gross Profit13.8 B € · 51%Operating Income2.9 B € · 11%Pre-tax Income2.5 B € · 9%Net Income1.8 B € · 7%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue27.3 B €-1.2%
Gross Profit13.8 B €+5.5%
Operating Income2.9 B €+44.0%
EBITDA4.4 B €-7.7%
Net Income1.8 B €+107.0%

Peer Comparison· Packaged Foods

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
BN-0.3%50.6%16.1%6.7%
KHC-1.7%33.3%-14.0%-23.0%
GIS-5.4%33.6%1.6%-0.5%
MKC9.5%38.6%18.6%22.0%
HRL2.5%15.7%8.2%3.8%
SJM3.7%33.5%11.3%-1.5%
Industry median3.5%20.5%10.1%1.9%
CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
BN-0.3%50.6%16.1%6.7%
RI-10.3%58.4%29.1%14.1%
OR1.3%76.6%24.3%13.9%
CA-3.7%17.5%5.4%0.4%
Industry median3.5%20.5%10.1%1.9%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
020 B40 B202020212022202320242025

Capital Structure

Q2 2025
Total Assets45.1 B
  • Equity16.9 B €38%
  • Current Liabilities14.6 B €32%
  • Long-term Liabilities13.5 B €30%

Key Figures

YoY change
Total Assets45.1 B €+1.3%
Total Liabilities28.1 B €-0.6%
Total Equity16.9 B €+4.6%
Cash & ST Investments6.6 B €+9.5%
Total Debt15.1 B €-3.1%
Net Debt13.1 B €-0.8%

Peer Comparison· Packaged Foods

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
BN0.9089.4%1.9537.5%
KHC1.2050.4%-4.8251.1%
GIS0.68183.7%43.4824.5%
MKC0.7870.5%3.3542.5%
HRL1.9435.9%1.9959.6%
SJM0.78127.9%6.8534.2%
Industry median1.5548.1%1.9949.7%
CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
BN0.9089.4%1.9537.5%
RI2.3387.9%3.8441.1%
OR1.4434.1%0.1956.5%
CA0.87142.1%2.0319.9%
Industry median1.5548.1%1.9949.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
02 B4 B202020212022202320242025

Cash Flow Bridge

Q2 2025 · TTM
02 B3.8 B €Operating-1.8 B €Investing-1.6 B €Financing396 M €Net Change

Key Figures

YoY change
Operating Cash Flow3.8 B €+9.8%
Capital Expenditures1.1 B €+24.6%
Free Cash Flow2.7 B €+5.0%
Dividends Paid0 €-100.0%

Peer Comparison· Packaged Foods

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
BN13.9%10.0%3.9%207.2%
KHC19.0%15.8%3.2%-82.4%
GIS11.8%8.8%2.9%-2,472.8%
MKC16.7%15.7%3.3%75.6%
HRL8.2%5.7%2.6%215.9%
SJM16.3%12.8%3.5%-1,062.4%
Industry median8.3%5.8%3.5%79.8%
CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
BN13.9%10.0%3.9%207.2%
RI16.8%11.6%5.2%119.2%
OR19.7%16.3%3.4%141.3%
CA4.2%2.6%1.8%1,113.8%
Industry median8.3%5.8%3.5%79.8%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.